Sarcoma  >>  Kinaction (masitinib)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kinaction (masitinib) / AB Science
NCT02009423 / 2013-004162-34: Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence

Terminated
3
7
NA
Masitinib, Placebo
AB Science
Gastro-Intestinal Stromal Tumour
11/15
11/15
NCT00812240 / 2008-000973-40: Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)

Terminated
3
335
Europe, US, RoW
Masitinib, AB1010, Imatinib, Gleevec
AB Science
Gastrointestinal Stromal Tumors
07/18
07/18
NCT01694277 / 2011-001790-41: Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

Hourglass Jul 2017 - Dec 2017 : From interim analysis of trial in GIST in second-line treatment
Completed
3
258
Europe, US
Masitinib, AB1010, Sunitinib, Sutent
AB Science
Gastrointestinal Stromal Tumors
12/20
12/20

Download Options